{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:49Z","timestamp":1792427869953,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:00:00Z","timestamp":1401840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-244x-14-164","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T07:03:20Z","timestamp":1401865400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lack of association of acute phase response proteins with hormone levels and antidepressant medication in perimenopausal depression"],"prefix":"10.1186","volume":"14","author":[{"given":"Sokratis E","family":"Karaoulanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina A","family":"Rizouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas A","family":"Rizoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikiforos V","family":"Angelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,4]]},"reference":[{"key":"1684_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL: A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010, 67: 446-457. 10.1016\/j.biopsych.2009.09.033.","journal-title":"Biol Psychiatry"},{"key":"1684_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J: Associations of depression with C-reactive protein, IL-1 and IL-6: a meta-analysis. Psychosom Med. 2009, 71: 171-186. 10.1097\/PSY.0b013e3181907c1b.","journal-title":"Psychosom Med"},{"key":"1684_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","volume":"19","author":"M Maes","year":"1995","unstructured":"Maes M: Evidence for an immune response in major depression: a review and major hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995, 19: 11-38. 10.1016\/0278-5846(94)00101-M.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"1684_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","volume":"70","author":"MK Wium-Andersen","year":"2013","unstructured":"Wium-Andersen MK, Orsted DD, Nielsen SF, Nordestgaard BG: Elevated C-reactive protein levels, psychological distress and depression in 73.131 individuals. JAMA Psychiatry. 2013, 70 (2): 176-184. 10.1001\/2013.jamapsychiatry.102.","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"1684_CR5","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1001\/archinte.164.9.1010","volume":"164","author":"DE Ford","year":"2004","unstructured":"Ford DE, Erlinger TP: Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004, 164 (9): 1010-1014. 10.1001\/archinte.164.9.1010.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1684_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/01.PSY.0000041542.29808.01","volume":"65","author":"M Danner","year":"2003","unstructured":"Danner M, Kasl SV, Abramson JL, Vaccarino V: Association between depression and elevated C-reactive protein. Psychosom Med. 2003, 65 (3): 347-356. 10.1097\/01.PSY.0000041542.29808.01.","journal-title":"Psychosom Med"},{"key":"1684_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00380962","volume":"235","author":"S Legros","year":"1985","unstructured":"Legros S, Mendlewicz , Wybran J: Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders. Eur Arch Psychiatry Clin Neurosci. 1985, 235: 9-11. 10.1007\/BF00380962.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1684_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-3083.1995.tb03604.x","volume":"41","author":"A Seidel","year":"1995","unstructured":"Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H: Cytokine production and serum proteins in depression. Scand J Immunol. 1995, 41: 534-538. 10.1111\/j.1365-3083.1995.tb03604.x.","journal-title":"Scand J Immunol"},{"key":"1684_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0165-1781(96)02783-7","volume":"64","author":"A Sluzewska","year":"1996","unstructured":"Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K: Indicators of immune activation in major depression. Psychiatry Res. 1996, 64: 161-167. 10.1016\/S0165-1781(96)02783-7.","journal-title":"Psychiatry Res"},{"key":"1684_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0165-0327(96)00026-2","volume":"39","author":"A Sluzewska","year":"1996","unstructured":"Sluzewska A, Rybakowski J, Sobieska M, Wiktorowicz K: Concentration and microheterogeneity glycophorms of a1-acid glycoprotein in major depressive disorder. J Affect Disord. 1996, 39: 149-155. 10.1016\/0165-0327(96)00026-2.","journal-title":"J Affect Disord"},{"key":"1684_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3999(97)00139-6","volume":"43","author":"M Berk","year":"1997","unstructured":"Berk M, Wadee AA, Kuschke RH, O\u2019Neill-Kerr A: Acute phase proteins in major depression. J Psychosom Res. 1997, 43: 529-534. 10.1016\/S0022-3999(97)00139-6.","journal-title":"J Psychosom Res"},{"issue":"5","key":"1684_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/01.psy.0000138132.66332.85","volume":"66","author":"KM Douglas","year":"2004","unstructured":"Douglas KM, Taylor AJ, O\u2019Malley PG: Relationship between depression and C- reactive protein in a screening population. Psychosom Med. 2004, 66 (5): 679-683. 10.1097\/01.psy.0000138132.66332.85.","journal-title":"Psychosom Med"},{"key":"1684_CR13","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0006-3223(92)90065-8","volume":"32","author":"PRHCR Joyce","year":"1992","unstructured":"Joyce PRHCR, Mulder RT, Sellman JD, Willson DA, Boswell DR: Elevated levels of acute phase proteins in major depression. Biol Psychiatry. 1992, 32: 1035-1041. 10.1016\/0006-3223(92)90065-8.","journal-title":"Biol Psychiatry"},{"key":"1684_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0278-5846(92)90056-K","volume":"16","author":"M Maes","year":"1992","unstructured":"Maes M, Scharpe S, Bosmans E, Vandewoude M, Suy E, Uyttenbroeck W, Cooreman W, Vandervorst C, Raus J: Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry. 1992, 16: 501-515. 10.1016\/0278-5846(92)90056-K.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1684_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/brbi.2000.0597","volume":"15","author":"EP Zorilla","year":"2001","unstructured":"Zorilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorcle R, Seligman DA, Schmidt K: The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun. 2001, 15: 199-226. 10.1006\/brbi.2000.0597.","journal-title":"Brain Behav Immun"},{"key":"1684_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0165-0327(92)90066-F","volume":"24","author":"M Maes","year":"1992","unstructured":"Maes M, Scharpe S, Van Grootel L, Uyttenbroeck W, Cooreman W, Cosyns P, Suy B: Higher alpha-1 antitrypsin, haptoglobin, seruloplasmin and lower retinal binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord. 1992, 24: 183-192. 10.1016\/0165-0327(92)90066-F.","journal-title":"J Affect Disord"},{"key":"1684_CR17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/0006-3223(93)90042-C","volume":"34","author":"M Maes","year":"1993","unstructured":"Maes M, Scharpe S, Meltzer HY, Cosyns P: Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression. Biol Psychiatry. 1993, 34: 690-701. 10.1016\/0006-3223(93)90042-C.","journal-title":"Biol Psychiatry"},{"key":"1684_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0165-1781(93)90027-E","volume":"49","author":"M Maes","year":"1993","unstructured":"Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P: Relationships between interleukin-6 activity, acute phase proteins and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res. 1993, 49: 11-27. 10.1016\/0165-1781(93)90027-E.","journal-title":"Psychiatry Res"},{"key":"1684_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1176\/ajp.151.1.112","volume":"151","author":"M Maes","year":"1994","unstructured":"Maes M, Delanghe J, Scharpe S, Meltzer HY, Cosyns P, Suy E, Bosmans E: Haptoglobin phenotypes and gene frequencies in unipolar major depression. Am J Psychiatry. 1994, 151: 112-116.","journal-title":"Am J Psychiatry"},{"key":"1684_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","volume":"66","author":"M Maes","year":"1997","unstructured":"Maes M, Delanghe J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpe S: Aute phase proteins in schizophrenia, mania and major depression modulation by psychotropic drugs. Psychiatry Res. 1997, 66: 1-11. 10.1016\/S0165-1781(96)02915-0.","journal-title":"Psychiatry Res"},{"key":"1684_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0165-0327(94)90135-X","volume":"30","author":"C Song","year":"1994","unstructured":"Song C, Dinan T, Leonard BE: Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord. 1994, 30: 283-288. 10.1016\/0165-0327(94)90135-X.","journal-title":"J Affect Disord"},{"issue":"6","key":"1684_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/mp.2012.144","volume":"18","author":"F Lamers","year":"2013","unstructured":"Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW: Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013, 18 (6): 692-699. 10.1038\/mp.2012.144.","journal-title":"Mol Psychiatry"},{"key":"1684_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0165-0327(89)90034-7","volume":"17","author":"M Maes","year":"1989","unstructured":"Maes M, Bosmans E, Suy E, Minner B, Raus J: Immune cell parameters in severely depressed patients: negative findings. J Affect Disord. 1989, 17: 121-128. 10.1016\/0165-0327(89)90034-7.","journal-title":"J Affect Disord"},{"key":"1684_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0278-5846(94)90079-5","volume":"18","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Stevens W, Calabrese J, Cosyns P: Natural killer cell activity in major depression: relation to circulating natural killer cells. Cellular indices of the immune response, and depressive phenomenology. Prog Neuropsychopharmacol Biol Psychiatry. 1994, 18: 717-730. 10.1016\/0278-5846(94)90079-5.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1684_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0165-1781(93)90081-Q","volume":"47","author":"M Maes","year":"1993","unstructured":"Maes M, Meltzer HY, Scharpe S, Cooreman W, Uyttenbroeck W, Suy E, Vandervorst C, Calabrese J, Raus J, Cosyns P: Psychomotor retardation, anorexia, weight loss, sleep disturbances and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatry Res. 1993, 47: 229-241. 10.1016\/0165-1781(93)90081-Q.","journal-title":"Psychiatry Res"},{"key":"1684_CR26","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0278-5846(93)90024-M","volume":"17","author":"C Mc Adams","year":"1993","unstructured":"Mc Adams C, Leonard BE: Neutrophil and monocyte phagocytosis in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 1993, 17: 971-984. 10.1016\/0278-5846(93)90024-M.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"1684_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1600-0447.1996.tb09849.x","volume":"94","author":"A Seidel","year":"1996","unstructured":"Seidel A, Arolt V, Hunstiger M, Rink L, Bechnisch A, Kirchner H: Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand. 1996, 94 (3): 198-204. 10.1111\/j.1600-0447.1996.tb09849.x.","journal-title":"Acta Psychiatr Scand"},{"key":"1684_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0165-0327(00)00157-9","volume":"63","author":"M Rothermundt","year":"2001","unstructured":"Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H: Inflammatory markers in major depression and melancholia. J Affect Disord. 2001, 63: 93-102. 10.1016\/S0165-0327(00)00157-9.","journal-title":"J Affect Disord"},{"key":"1684_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archpsyc.60.1.29","volume":"60","author":"BL Harlow","year":"2003","unstructured":"Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS: Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause. The Harvard Study of Mood and Cycles. Arch Gen Psychiatry. 2003, 60: 29-36. 10.1001\/archpsyc.60.1.29.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"1684_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00737-003-0036-2","volume":"7","author":"PJ Schmidt","year":"2004","unstructured":"Schmidt PJ, Murphy JH, Haq N, Rubinow DR, Danaceau MA: Stressful life events, personal losses and perimenopause related depression. Arch Womens Ment health. 2004, 7 (1): 19-26. 10.1007\/s00737-003-0036-2.","journal-title":"Arch Womens Ment health"},{"key":"1684_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archpsyc.61.1.62","volume":"61","author":"EW Freeman","year":"2004","unstructured":"Freeman EW, Sammel M, Liu L, Gracia CR, Nelson DB, Hollander L: Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004, 61: 62-70. 10.1001\/archpsyc.61.1.62.","journal-title":"Arch Gen Psychiatry"},{"key":"1684_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/archpsyc.63.4.375","volume":"63","author":"EW Freeman","year":"2006","unstructured":"Freeman EW, Sammel MD, Lin H, Nelson DB: Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006, 63: 375-382. 10.1001\/archpsyc.63.4.375.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"1684_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/gme.0b013e3181db9f8b","volume":"17","author":"EW Freeman","year":"2010","unstructured":"Freeman EW: Associations of depression with the transition to menopause. Menopause. 2010, 17 (4): 823-827. 10.1097\/gme.0b013e3181db9f8b.","journal-title":"Menopause"},{"key":"1684_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","volume":"100","author":"M Cushman","year":"1999","unstructured":"Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, Sakkinen PA, Tracy RP: Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Study. Circulation. 1999, 100: 717-722. 10.1161\/01.CIR.100.7.717.","journal-title":"Circulation"},{"key":"1684_CR35","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0024-3205(03)00425-9","volume":"73","author":"DM Dreon","year":"2003","unstructured":"Dreon DM, Slavin JL, Phinney SD: Oral contraceptive use and increased plasma concentration of C-reactive protein. Life Sci. 2003, 73: 1245-1252. 10.1016\/S0024-3205(03)00425-9.","journal-title":"Life Sci"},{"key":"1684_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-2143(97)90060-3","volume":"130","author":"B Jilma","year":"1997","unstructured":"Jilma B, Dimberger E, Loscher I, Rumplmayr A, Hildebrandt J, Eichler HG, Kapiotis S, Wagner OF: Menstrual cycle associated changes in blood levels of interleukin-6, alpha 1 acid glucoprotein and C-reactive protein. J Lab Clin Med. 1997, 130: 69-75. 10.1016\/S0022-2143(97)90060-3.","journal-title":"J Lab Clin Med"},{"issue":"2","key":"1684_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.maturitas.2006.02.001","volume":"55","author":"O Ozturk","year":"2006","unstructured":"Ozturk O, Eraslan D, Mete HE, Ozsener S: The risk factors and symptomatology of perimenopausal depression. Maturitas. 2006, 55 (2): 180-186. 10.1016\/j.maturitas.2006.02.001.","journal-title":"Maturitas"},{"key":"1684_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1744-859X-11-9","volume":"11","author":"SE Karaoulanis","year":"2012","unstructured":"Karaoulanis SE, Daponte A, Rizouli KA, Rizoulis AA, Lialios GA, Theodoridou CT, Christakopoulos C, Angelopoulos NV: The role of cytokines and hot flashes in perimenopausal depression. Annal Gen Psychiatry. 2012, 11: 9-10.1186\/1744-859X-11-9.","journal-title":"Annal Gen Psychiatry"},{"key":"1684_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0020-7292(02)00189-3","volume":"79","author":"T Ushiroyama","year":"2002","unstructured":"Ushiroyama T, Ikeda A, Ueki M: Elevated plasma interleukin 6 (IL-6) and soluble IL-6 receptor concentrations in menopausal women with and without depression. Int J Gynecol Obstet. 2002, 79: 51-52. 10.1016\/S0020-7292(02)00189-3.","journal-title":"Int J Gynecol Obstet"},{"key":"1684_CR40","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","volume":"289","author":"SA Shumaker","year":"2003","unstructured":"Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J, WHIMS Investigators: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003, 289: 2651-2662. 10.1001\/jama.289.20.2651.","journal-title":"JAMA"},{"key":"1684_CR41","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","volume":"291","author":"SA Shumaker","year":"2004","unstructured":"Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women\u2019s Health Initiative Memory Study. JAMA. 2004, 291: 2947-2958. 10.1001\/jama.291.24.2947.","journal-title":"JAMA"},{"key":"1684_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1196\/annals.1347.005","volume":"1052","author":"RD Brinton","year":"2005","unstructured":"Brinton RD: Investigative models for determining hormone therapy-induced outcomes in brain. Evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci. 2005, 1052: 57-74. 10.1196\/annals.1347.005.","journal-title":"Ann N Y Acad Sci"},{"key":"1684_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.nbd.2006.06.001","volume":"24","author":"YC Chang","year":"2006","unstructured":"Chang YC, Tzeng SF, Yu L, Huang AM, Lee HT, Huang CC, Ho CJ: Early-life fluoxetine exposure reduced functional deficits after hypoxic-ischemia brain injury in rat pups. Neurobiol Dis. 2006, 24: 101-113. 10.1016\/j.nbd.2006.06.001.","journal-title":"Neurobiol Dis"},{"key":"1684_CR44","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.neuroimage.2009.07.072","volume":"49","author":"IH Li","year":"2010","unstructured":"Li IH, Huang WS, Shiue CY, Huang YY, Liu RS, Chyueh SC, Hu SH, Liao MH, Shen LH, Liu JC, Ma KH: Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET. Neuroimage. 2010, 49: 1259-1270. 10.1016\/j.neuroimage.2009.07.072.","journal-title":"Neuroimage"},{"key":"1684_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2009.04.053","volume":"1281","author":"Y Jin","year":"2009","unstructured":"Jin Y, Lim CM, Kim SW, Park JY, Seo JS, Han PL, Yoon SH, Lee JK: Fluoxetine attenuates kainic acid induced neuronal cell death in the mouse hippocampus. Brain Res. 2009, 1281: 108-116.","journal-title":"Brain Res"},{"key":"1684_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/156720207779940707","volume":"4","author":"SJ Chen","year":"2007","unstructured":"Chen SJ, Kao CL, Chang YL, Yen CJ, Shui JW, Chien CS, Chen IL, Tsai TH, Ku HH, Chiou SH: Anti depressant administration modulates neural stem cell survival and serotoninergic differentiation through bcl-2. Curr Neurovasc Res. 2007, 4: 19-29. 10.2174\/156720207779940707.","journal-title":"Curr Neurovasc Res"},{"key":"1684_CR47","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1016\/S1353-8020(11)70066-9","volume":"18S1","author":"F Zhang","year":"2012","unstructured":"Zhang F, Zhou H, Wilson BL, Shi JS, Hong JS, Gao HM: Fluoxetine protect neurons against microglial activation-mediated neurotoxicity. Parkinsonism Relat Disord. 2012, 18S1: S213-S217.","journal-title":"Parkinsonism Relat Disord"},{"key":"1684_CR48","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/jnr.21899","volume":"87","author":"CM Lim","year":"2009","unstructured":"Lim CM, Kim SW, Park JY, Kim C, Yoon SH, Lee JK: Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res. 2009, 87: 1037-1045. 10.1002\/jnr.21899.","journal-title":"J Neurosci Res"},{"key":"1684_CR49","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1523\/JNEUROSCI.22-09-03673.2002","volume":"22","author":"S Nakagawa","year":"2002","unstructured":"Nakagawa S, Kim JE, Lee R, Malberg JE, Chen J, Steffen C, Zhang YJ, Nestler EJ, Duman RS: Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci. 2002, 22: 3673-3682.","journal-title":"J Neurosci"},{"key":"1684_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neulet.2013.06.033","volume":"550","author":"M Taler","year":"2013","unstructured":"Taler M, Miron O, Gil-Ad I, Weizman A: Neurocognitive and procognitive effects of sertraline: In vitro and in vivo studies. Neurosci Lett. 2013, 550: 93-97.","journal-title":"Neurosci Lett"},{"key":"1684_CR51","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.pnpbp.2011.01.009","volume":"35","author":"M Erdem","year":"2011","unstructured":"Erdem M, Celic C, Cayci T, Ozderim B, Kurt YG, Akgul EO, Yaman H, Balikci A, Uzun O: Serum haptoglobin levels in patients with melancholic and nonmelancholic major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011, 35: 944-947. 10.1016\/j.pnpbp.2011.01.009.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"S","key":"1684_CR52","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S0378-5122(02)00011-7","volume":"41","author":"M Banger","year":"2002","unstructured":"Banger M: Affective syndromes during perimenopause. Maturitas. 2002, 41 (S): S13-S18.","journal-title":"Maturitas"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-14-164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-14-164\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-14-164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T07:38:08Z","timestamp":1565509088000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-14-164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,4]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-14-164","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,4]]},"article-number":"164"}}